Convergence Financial, LLC Novartis Ag Transaction History
Convergence Financial, LLC
- $471 Billion
- Q3 2024
A detailed history of Convergence Financial, LLC transactions in Novartis Ag stock. As of the latest transaction made, Convergence Financial, LLC holds 3,794 shares of NVS stock, worth $405,237. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,794
Previous 5,283
28.18%
Holding current value
$405,237
Previous $562 Million
22.41%
% of portfolio
0.09%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,434Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.3 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$792 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$791 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$635 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...